Login / Signup

Type 2 Diabetic Sepsis Patients Have a Lower Mortality Rate in Pioglitazone Use: A Nationwide 15-Year Propensity Score Matching Observational Study in Taiwan.

Ming-Shun HsiehSung-Yuan HuShu-Hui LiaoChia-Ming ChangVivian Chia-Rong HsiehChorng-Kuang How
Published in: Emergency medicine international (2021)
This first human cohort study demonstrated the potential protective effect of chronic pioglitazone use in type 2 diabetic sepsis patients.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • acute kidney injury
  • intensive care unit
  • peritoneal dialysis
  • endothelial cells
  • type diabetes
  • cross sectional
  • septic shock